Prof. Angela Tincani recommends the Autoimmunity Congress to gynecologists and obstetricians.
"It is well known that the physiological functioning of the reproductive system is linked to the immune system good health. Many efforts in basic and clinical medicine have been made to clarify this relationship with the final purpose to offer a cure to many young women with these problems.
During the next Autoimmunity Congress you will hear all the recent achievements in the area of recurrent miscarriages (the Good, the Bad and the Ugly by Caterina de Carolis, Italy) and their prevention (IVIG use by Howard Carp, Israel) as well as the involvement of immune system in physiology and pathology of reproduction (The role of Complement by Franco Tedesco, Italy). The involvement of both organ and non-organ specific autoantibodies (reported by Chunyu Huang, China) and different autoimmune diseases in the impairment of pregnancy development and outcome will be presented. Most importantly during the Congress several treatment strategies will be depicted. Simple drugs such as hydroxicloroquine will be shown to stop pregnancy loss patients with antiphospholipid syndrome without any benefit by heparin and low dose aspirin (An European multicentric study presented by Arsene Mekinian). A modern obstetric view should cancel the belief that during pregnancy any drug is dangerous. In this respect a complete review on the use of synthetic and biologic antirheumatic drugs in pregnancy (by Roger Levy, Brazil) will be of the greatest help.
View the session on Pregnancy and autoimmunity.pdf
View the session on the autoimmune basis of reproductive failure.pdf
View the session on APS - diagnostics and challenges for the future.pdf
Angela Tincani is Professor of Rheumatology, University of Brescia and Head of Rheumatology and Clinical Immunology, Brescia General Hospital, Italy.
After receiving her MD from the University of Milan in 1974, Professor Tincani continued postgraduate studies in Allergology and Clinical Immunology (1977), Haematology (1979) and Rheumatology (1983), before taking up several senior positions in Rheumatology and Clinical Immunology as full Professor and Chair in Rheumatology at University of Brescia and since 2010 Head of Rheumatology and Clinical Immunology Unit of Spedali Civili, Brescia.
Main clinical and research area: pathogenesis, diagnosis and treatment of systemic autoimmune diseases in particular systemic lupus erythematosus and antiphospholipid syndrome; management of pregnancy in patients with inflammatory arthritis and systemic autoimmune diseases: biomarkers of outcome and use of anti-rheumatic drugs in pregnant patients; evolution of autoantibodies determinations and reliability and clinical significance of emerging new technology. All the above quoted research are conducted within national/international networks.
Professor Tincani has been included in the organization or in the scientific committee of many national and international congresses including the International Congress on Autoimmunity series since 1999 (Tel Aviv).
She has served on many international committees for research and education in lupus, most recently the EULAR committee "Points to consider for use of antirheumatic drugs before pregnancy and during pregnancy and lactation" (2013–14) and, as co-chair, "Recommendations for the management of family planning, assisted reproduction, gestation, delivery and menopause in patients with Systemic Lupus Erythematosus.
Professor Tincani is a widely published author (300 publications indexed by PubMed with nearly 11000 citations and H-index 50 (by WOS). She is regional Editor (Europe) of the journal Autoimmunity and sits on the Editorial Boards of Clinical and Experimental Rheumatology and Autoimmunity Reviews.